Results 71 to 80 of about 1,949 (176)

The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout

Nephrology, Volume 29, Issue 8, Page 547-550, August 2024.
Abstract Gout affects 15%–30% of individuals with advanced kidney disease. Allopurinol which is rapidly and extensively metabolised to an active metabolite, oxypurinol, is the most commonly prescribed urate‐lowering therapy. Oxypurinol is almost entirely eliminated by the kidneys (>95%) and has an elimination half‐life of 18–30 h in those with normal ...
Luke C. Wilson, Jacob Ward, Daniel F. B. Wright, Suetonia C. Green, Sophie L. Stocker, Tracey L. Putt, John B. W. Schollum, Robert J. Walker   +7 more
wiley   +1 more source

A prospective, randomized, multicenter, open‐label trial comparing survival in subjects receiving peritoneal dialysis or conventional in‐center hemodialysis

Medicine Advances, Volume 2, Issue 2, Page 112-122, June 2024.
Abstract Background Peritoneal dialysis (PD) and conventional in‐center hemodialysis (HD) are treatment options for patients with end‐stage kidney disease (ESKD). However, their impact on all‐cause mortality is unclear. Methods We conducted a multicenter, open‐label, randomized, non‐inferiority trial to determine the effect of dialysis modality on ...
Li Fan, Xiao Yang, Huaying Shen, Menghua Chen, Hao Zhang, Zhaohui Ni, Hongli Lin, Hongtao Yang, Qinkai Chen, Hongyu Chen, Gengru Jiang, Jianqin Wang, Jiuyang Zhao, Zhuxing Sun, Aiping Yin, Aili Jiang, Yun Li, Hui Peng, Nan Chen, Chuanming Hao, Yaozhong Kong, Rong Rong, Jie Li, Xia Zou, Haotian Luo, Jiaqi Qian, Xueqing Yu   +26 more
wiley   +1 more source

A surprising situation due to icodextrin (ıcodextrin peritonitis) [PDF]

, 2015
Periton diyalizi (PD) 30 yılı aşkın bir süredir kronik renal replasman tedavisi için başarılı bir yöntemolmuştur. Icodextrin periton diyalizinde (PD) ultrafltrasyon yönetimi için büyük bir yeniliktir.Günümüzde, yüksek glükoz içeren çözeltilerin uzun ...
Ulu, Sena Memnune, Yüksel, Şeref, Polat, Mehmet   +2 more
core  

Icodextrin’e Bağlı Şaşırtıcı Bir Durum (Icodextrin Peritoniti)

Turkish Journal of Nephrology, 2019
Peritoneal dialysis (PD) has been a successful modality for chronic renal replacement therapy for more than 30 years. Icodextrin has been a major addition to the management of ultrafiltration in peritoneal dialysis (PD).
Sena Memnune ULU, Mehmet POLAT, Şeref YÜKSEL   +2 more
doaj  

Single Daily Icodextrin Exchange as Initial and Solitary Therapy

, 2017
Background Incremental dialysis utilizes gradually increasing dialysis doses in response to declines in residual kidney function, and it is the preferred renal replacement therapy for patients who have just transitioned to end-stage renal disease (ESRD).
Sloand, James A, Agar, Baris U, James A. Sloand, Baris U. Agar   +3 more
core   +1 more source

Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry

, 2020
Background: Icodextrin is a high molecular weight, starch-derived glucose polymer that is used as an osmotic agent in peritoneal dialysis (PD) to promote ultrafiltration. There has been wide variation in its use across Australia and the rest of the world,
Borlace, Monique, Johnson, David W., Badve, S., Borlace, M., Sud, Kamal, Clayton, Philip, Guddattu, Vasudeva, Rangaswamy, D., Webster, Angela C., Boudville, N., Webster, A.C., Clayton, P., Boudville, Neil, Sud, K., Badve, Sunil, Guddattu, V., Rangaswamy, Dharshan, Johnson, D.W.   +17 more
core   +1 more source

Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study [PDF]

, 2017
Although icodextrin solution has been highlighted in the fluid management compared to glucose-based solutions, proof of a beneficial effect of icodextrin solution on residual renal function (RRF) is lacking.
유태현, 한승혁
core   +1 more source

Icodextrin metabolism in peritoneal dialysis : clinical and experimental studies

, 2007
Icodextrin is a glucose polymer which is used as osmotic agent to provide sustained ultrafiltration (UF) during the long (8-16 hours) dwell in end-stage renal disease patients undergoing peritoneal dialysis (PD).
Elvia Garcia Lopez (19526608)
core  

Interferring Substance in Point-of-Care Testing Glucometer

Journal of Health Science and Medical Research (JHSMR), 2011
Glucometer, a point-of-care testing device for determination of blood glucose level, is widelyused in medical clinic and for self-monitoring blood glucose.
Limthong Promdee, Jirawat Mingchai, Suparada Tinkachat, Wanlaya Sitti, Khaekhai Pikapaid, Sirawich Sonsok, Nongluk Champee, Chainarong Thong-aon   +7 more
doaj  

Comparison of Icodextrin- and Glucose-Based Peritoneal Dialysis Fluids in Their Acute and Chronic Effects on Human Peritoneal Mesothelial Cells

, 2007
BackgroundIcodextrin-based peritoneal dialysis fluids (PDFs) display several features that may potentially improve their biocompatibility compared to conventional glucose-containing solutions.
J. Witowski, K. KsąŻEk, A. Jörres, T. O. Bender   +3 more
core   +1 more source